ANIP Latest Headlines

ANI Pharmaceuticals Shareholders Approve Amended 2022 Incentive Plan

at www.tipranks.com (Thu, 21-May 4:31 PM)

ANI Pharmaceuticals Lifts 2026 Outlook on Rare Disease Momentum and Robust Q1 Results

Market Chameleon (Fri, 8-May 8:02 AM)

ANI Pharmaceuticals Sets New Records as Rare Disease Revenue Soars 84% in 2025 and 2026 Outlook Tops $1 Billion

Market Chameleon (Fri, 27-Feb 9:21 AM)